IMAGENT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Imagent, and when can generic versions of Imagent launch?
Imagent is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs.
The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.
Summary for IMAGENT
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 5,295 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IMAGENT at DailyMed |
US Patents and Regulatory Information for IMAGENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alliance Pharm | IMAGENT | perflubron | LIQUID;ORAL | 020091-001 | Aug 13, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMAGENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMAGENT
See the table below for patents covering IMAGENT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 973489 | ⤷ Try a Trial | |
European Patent Office | 0812214 | ⤷ Try a Trial | |
Japan | 2005263804 | STABLE GAS EMULSION CONTAINING PHOSPHOLIPID FOR ULTRASOUND CONTRAST ENHANCEMENT | ⤷ Try a Trial |
European Patent Office | 1550464 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |